Cargando…
The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum
Gastroesophageal reflux disease (GERD) is a highly prevalent chronic condition where in stomach contents reflux into the esophagus causing symptoms, esophageal injury, and subsequent complications. Proton pump inhibitors (PPI) remain the mainstay of therapy for acid suppression. Despite their effica...
Autores principales: | Hussain, Zilla H, Henderson, Emily E, Maradey-Romerao, Carla, George, Nina, Fass, Ronnie, Lacy, Brian E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816276/ https://www.ncbi.nlm.nih.gov/pubmed/26270485 http://dx.doi.org/10.1038/ctg.2015.32 |
Ejemplares similares
-
The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum
por: Hussain, Zilla H, et al.
Publicado: (2015) -
New and Future Drug Development for Gastroesophageal Reflux Disease
por: Maradey-Romero, Carla, et al.
Publicado: (2014) -
Comparison of Clinical Characteristics of Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Versus Those Who Fully Responded
por: Dickman, Ram, et al.
Publicado: (2011) -
Sa143 THE RISK OF COVID-19 IS HIGHER IN FEMALES USING PROTON PUMP INHIBITORS
por: Ghoneim, Sara, et al.
Publicado: (2021) -
Unmet Needs in the Treatment of Gastroesophageal Reflux Disease
por: Dickman, Ram, et al.
Publicado: (2015)